九典制药: 董事会决议公告

Meeting Overview - The fourth meeting of the board of directors of Hunan Jiutian Pharmaceutical Co., Ltd. was held on August 21, 2025, with all seven directors present, ensuring compliance with legal and regulatory requirements [1] Financial Reporting - The board approved the 2025 semi-annual report and its summary, confirming that the report accurately reflects the company's actual situation without any false records or misleading statements [1][3] Fund Utilization - The board reviewed and approved the special report on the use of raised funds for the first half of 2025, affirming that it accurately represents the actual situation regarding the storage and use of raised funds [3] - The board agreed to change the purpose of the raised funds, stating that the adjustment is necessary for the company's operations and development, aligning with market demands and strategic goals [3] Company Charter Amendments - The board proposed amendments to the company charter, including an increase in registered capital from RMB 496,196,815 to RMB 500,212,355, and the total number of shares from 496,196,815 to 500,212,355 [3][4] Shareholder Meeting - The board approved the convening of the first temporary shareholders' meeting of 2025 on September 9, 2025, at 14:45 in the company meeting room [4][5]